Válts MeRSZ+ -ra!

MeRSZ online
okoskönyvtár

Több száz tankönyv egy helyen.
Online. Bárhol. Bármikor.

Fazekas Tamás, Merkely Béla, Papp Gyula, Tenczer József (szerk.)

Klinikai szív-elektrofiziológia és aritmológia

Irodalom

  1. Adachi, K. et al.: Determinant of microvolt-level T-wave alternans in patients with dilatated cardiomyopathy. J. Am. Coll. Cardiol., 1999, 34: 374–380.
  2. Adam, D. R. et al.: Ventricular fibrillation and fluctuation in the magnitude of the repolarization vector. I. E. E. E. Comp. Cardiol., 1982, 241–244.
  3. Amoundas, A. A., Tomaselli, G. F., Esperer, H. D.: Pathophysiological basis and clinical application of T-wave alternans. J. Am. Coll. Cardiol., 2002, 40: 207–217.
  4. Bardaji, A., Vidal, F., Richart, C.: T-wave alternans associated with amiodarone. J. Electrocardiol., 1993, 26: 155-157.
  5. Bardy, G. H. et al.: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med., 2005, 352: 225–237.
  6. Bigger, J. T.: Expanding indications for implantable cardiac defibrillation. N. Engl. J. Med., 2002, 346: 931–933.
  7. Bloomfield, D. M. et al.: Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J. Am. Coll. Cardiol., 2006, 47: 456–463.
  8. Bloomfield, D. M. et al.: Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation, 2004, 110: 1885–1889.
  9. Bloomfield, D. M. et al.: The immediate reproducibility of T wave alternans during bicycle exercise. Pacing Clin. Electrophysiol., 2002, 25: 1185–1191.
  10. Bloomfield, D. M., Hohnloser, S. H., Cohn, R. J.: Interpratation and classification of T wave alternans tests. J. Cardiovasc. Electrophysiol., 2002, 13: 502–512.
  11. Burattini, L. et al.: ECG features of microvolt T-wave alternans in coronary artery disease and long QT syndrome patients. J. Electrocardiol., 1998, 31Suppl.: 114–120.
  12. Buxton, A. E. et al.: Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables. Circulation, 1999, 99: 1843–1850.
  13. Buxton et al.: Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med., 2000, 342: 1937–1945.
  14. Chan, P. S. et al.: Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population. J. Am. Coll. Cardiol., 2006, 48: 112–121.
  15. Chinushi, M. et al: Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long QT syndrome. Circ. Res., 1998, 83: 614–628.
  16. Chow, T. et al.: Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J. Am. Coll. Cardiol., 2007, 49: 50–58.
  17. Chow, T. et al.: Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J. Am. Coll. Cardiol., 2006, 47: 1820–1827.
  18. Cruz Filho, F. et al.: Electrical behavior of T-wave polarity alternans in patients with congenital long QT syndrome. J. Am. Coll. Cardiol., 2000, 36: 167–173.
  19. Estes, N. A., 3rd et al.: Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am. J. Cardiol., 1999, 80: 1314–1318.
  20. Gehi, A. K. et al.: Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J. Am. Coll. Cardiol., 2005, 46: 75–82.
  21. Gold, M. R. et al.: A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J. Am. Coll. Cardiol., 2000, 36: 2247–2253.
  22. Grimm, W. et al.: Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation, 2003, 108: 2883–2891.
  23. Groh, W. J. et al.: Amioarone reduce the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J. Cardiovasc. Electrophysiol., 1999, 10: 1335–1339.
  24. Habbab, M. A., el-Sherif, N.: TU alternans, long QTU, and torsade de pointes: clinical and experimental observations. Pacing Clin. Electrophysiol., 1992, 15: 916–931.
  25. Hennersdorf, M. G. et al.: T-wave alternans as a risk predictor in patients with cardiomyopathy and mild-to-moderate heart failure, Pacing Clin Electrophysiol., 2000, 23: 1386–1391.
  26. Hering, H. E.: Das Wesen des Herzalternans. Muench Med Wochenschr., 1908, 4: 1417–1421.
  27. Hohnloser, S. H.: T-Wave alternans in Cardiac Electrophysiology: From Cell to Bedside. Eds: Zipes, D. P., & Jalife J. 4th edition. Saunders, Elsevier Inc., 2004, 839–847.
  28. Hohnloser, S. H. et al.: T-wave alternans in post myocardial infarction patients (ACES Pilot study) abstract, J. Am. Coll. Cardiol., 1999, 33: 144A.
  29. Hohnloser, SH. et al.: T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet, 2003, 362: 125–126.
  30. Hohnloser, S. H. et al.: Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J. Am. Coll. Cardiol., 2003, 41: 2220–2224.
  31. Hohnloser, S. H. et al.: T wave alternans during exercise and atrial pacing in humans. J. Cardiovasc. Electrophysiol., 1997, 8: 987–993.
  32. Hohnloser, S. H. et al.: T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J. Cardiovasc. Electrophysiol., 1998, 9: 1258–1268.
  33. Houltz, B. et al.: Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study. Pacing Clin. Electrophysiol., 1998, 21: 1044–1057.
  34. Ikeda, T. et al.: Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J. Am. Coll. Cardiol., 2000, 35: 722–730.
  35. Ikeda, T. et al.: T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am. J. Cardiol., 2002, 89: 79–82.
  36. Ikeda, T. et al.: Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac fun) ction after acute myocardial infarction: results of a collaborative cohort study. J. Am. Coll. Cardiol., 2006, 48: 2268–2274.
  37. Kalter, H. H., Schwartz, M. L.: Electrical Alternans. N. Y. State J. Med., 1948, 1: 1164–1166.
  38. Kaufman, E. S. et al.: Influence of heart rate and sympathetic stimulation on arrhythmogenic T wave alternans. Am. J. Physiol. Heart Circ. Physiol., 2000, 279: H1748–1756.
  39. Kavesh, N. G. et al.: The effect of procainamide on T wave alternans. J. Cardiovasc. Electrophysiol., 1999, 10: 649–654.
  40. Kitamura, H., et al.: Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J. Am. Coll. Cardiol., 2002, 39: 295–300.
  41. Klingenheben T., et al. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. J. Am. Coll. Cardiol., 2001, 38: 2013–2019.
  42. Klingenheben, T., et al.: Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet, 2000, 356: 651–652.
  43. Kober, L. et al.: Importance of congestive heart failure and interaction of congestive heart failure and left ventricular systolic function on prognosis in patients with acute myocardial infarction. Am. J. Cardiol., 1996, 78: 1124–1128.
  44. Koller, M. L. et al.: Altered dynamics of action potential restitution and alternans in humans with structural heart disease. Circulation, 2005, 112: 1542–1548.
  45. Komiya, N. et al.: The influence of beta-adrenergic agonists and antagonists on T-wave alternans in patients with and without ventricular tachyarrhythmia. Pacing Clin. Electrophysiol., 2005, 28: 680–684.
  46. Kuo, C. S. et al.: Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation, 1983, 67: 1356–1367.
  47. Lee, H. C. et al.: Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo 1. Correlation with monophasic action potentials and contraction. Circulation, 1988, 78: 1047–1059.
  48. Lorell, B. H., Pericardial Disease. In: Heart Disease: A Textbook of Cardiovascular Medicine, Braunwald, E. (Ed.) WB Saunders, Philadelphia, 1997, 1478–1534.
  49. Lewis, T.: Notes upon alternation of the heart. Q. J. Med. 4: 141–144, 1910.
  50. Moss, A. J., Daubert, J., Zareba, W.: MADIT-II: clinical implications. Card. Electrophysiol. Rev., 2002, 6: 463–465.
  51. Momiyama, Y. et al.: Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy. Jpn. Circ. J., 1997, 61: 650–656.
  52. Narayan, S. M.: T-wave alternans and the susceptibility to ventricular arrhythmias. J. Am. Coll. Cardiol., 2006, 47: 269–281.
  53. Narayan, S. M., Lindsay, B. D., Smith, J. M.: Demonstrating the proarrhythmic preconditioning of single premature extrastimuli using the magnitude, phase and temporal distribution of repolarization alternans. Circulation, 1999, 100: 1887–1893.
  54. Narayan, S. M. et al.: T-wave alternans phase following ventricular extrasystoles predicts arrhythmia-free survival. Heart Rhythm., 2005, 2: 234–241.
  55. Narayan, S. M., Smith, J. M.: Spectral analysis of periodic fluctuations in electrocardiographic repolarization. IEEE Trans. Biomed. Eng., 1999, 46: 203–212.
  56. Narayan, S. M., Smith, J. M.: Differing rate dependence and temporal distribution of repolarization alternans in patients with and without ventricular tachycardia. J. Cardiovasc. Electrophysiol., 1999, 10: 61–71.
  57. Narayan, S. M., Smith, J. M.: Exploiting rate-related hysteresis in repolarization alternans to improve risk stratification for ventricular tachycardia. J. Am. Coll. Cardiol., 2000, 35: 1485–1492.
  58. Nearing, B. D., Huang, A. H., Verrier, R. L.: Dynamic tracking of cardiac vulnerability by complex demodulation of the T wave. Science, 1991, 252: 437–440.
  59. Pastore, J. M. et al.: Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation, 1999, 99: 1385–1395.
  60. Rashba, E. J. et al.: Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation a prospective study in subjects with chronic ischemic heart disease. J. Cardiovasc. Electrophysiol., 2004, 15: 170–176.
  61. Rashba, E. J. et al.: Effects of selective autonomic blockade on T-wave alternans in humans. Circulation, 2002, 105: 837–842.
  62. Rosenbaum, D. S. et al.: Electrical alternans and vulnerability to ventricular arrhythmias. N. Engl. J. Med., 1994, 330: 235–241.
  63. Sakabe, K. et al.: Comparison of T-wave alternans and QT dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: A prospective study. Jpn. Heart. J., 2001, 42: 451–457.
  64. Schwab, J. et al.: Incidence of T wave alternation after acute myocardial infarction and correlation with other prognostic parameters results of a prospective study, Pacing Clin. Electrophysiol., 2001, 24: 957–961.
  65. Schwartz, P. J., Malliani, A.: Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am. Heart J., 1975, 89: 45–50.
  66. Schwartz, P. J. et al.: Diagnostic criteria for the long QT syndrome. An update. Circulation, 1993, 88: 782–784.
  67. Selvaraj, R. J. et al.: Endocardial and epicardial repolarization alternans in human cardiomyopathy: evidence for spatiotemporal heterogeneity and correlation with body surface T-wave alternans. J. Am. Coll. Cardiol., 2007, 49: 338–346.
  68. Shimizu, W., Antzelevitch, C.: Cellular and ionic basis for T-wave alternans under long-QT conditions. Circulation, 1999, 99: 1499–1507.
  69. Smith, J. M. et al.: Subtle alternating electrocardiographic morphology as an indicator of decreased cardiac electrical stability. Comput. Cardiol., 1985 12: 109–112.
  70. Smith, J. M. et al.: Electrical alternans and cardiac electrical instability. Circulation, 1988, 77: 110–121.
  71. Smith, J. M., Cohen, R. J.: Simple finite-element model accounts for wide range of cardiac dysrhythmias. Proc. Natl. Acad. Sci. U. S. A., 1984, 81: 233–237.
  72. Surawicz, B., Fisch, C.: Cardiac alternans: diverse mechanisms and clinical manifestations. J. Am. Coll. Cardiol., 1992, 20: 483–499.
  73. Tapanainen, J. M., Still, A. M., Airaksinen, K. E., Huikuri, H. V.: Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow-up study. J. Cardiovasc. Electrophysiol., 2001, 12: 645–652.
  74. Verrier, R. L. et al.: Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic events. J. Cardiovasc. Electrophysiol., 2003, 14: 705–711.
  75. Walker, M. R., Rosenbaum, D. S.: Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death. Cardiovasc. Res., 2003, 57: 599–614.
  76. Zabel, M. et al.: Microvolt and macrovolt alternans of action potentials and the T wave in an isolated rabbit heart model (abstract). Circulation, 1998, 98: 1–10.
  77. Zacks, E. S.: Effect of oral beta-blocker therapy on microvolt T-wave alternans and electrophysiology testing in patients with ischemic cardiomyopathy. Am. Heart J., 2007, 153: 392–397.
  78. Zareba, W., Moss, A. J., le Cessie, S., Hall, W. J.: T wave alternans in idiopathic long QT syndrome. J. Am. Coll. Cardiol., 1994, 23: 1541–1546.
  79. Zipes, D. P. et al.: ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J. Am. Coll. Cardiol., 2006, 48: 247–346.
Klinikai szív-elektrofiziológia és aritmológia

Tartalomjegyzék

Kiadó: Akadémiai Kiadó

Online megjelenés éve: 2016

ISBN: 978 963 059 748 7

Orvostudomány

A Klinikai szív-elektrofiziológia és aritmológia első kiadását a szívritmuszavarok patofiziológiájában, farmakológiájában, diagnosztikájában és gyógyításában kiemelkedően jártas hazai szakírók vetették papírra. Az aritmiában szenvedő betegek optimális ellátásához nélkülözhetetlen, az idő tájt rendelkezésre álló elméleti és klinikai tudnivalókat átfogóan ismertető kézikönyv iránti olvasói érdeklődés és a Magyar Tudományos Akadémia Orvosi Osztályának Nívódíja bizonyította, hogy a szerzők és a szerkesztők erőfeszítései nem voltak haszontalanok. Egy évtized az élettudományok fejlődésének jelenlegi tempóját figyelembe véve nagyon hosszú idő. Az elektrofiziológia és (a)ritmológia mind a mai napig a szívgyógyászat egyik legdinamikusabban fejlődő technicizálódó ága, melynek vertikuma egyre nagyobb: a szívizom szabályos ritmikáját megzavaró, nemritkán öröklődő patobiokémiai eltérések felismerésétől az új típusú, innovatív gyógyszerek hozzáértő alkalmazásán keresztül az egyre kifinomultabb invazív terápiás eljárásokig ível. Ennélfogva idő- és szükségszerűvé vált a lényegbevágóan új diagnosztikai / képalkotó módszerek, gyógyszeres és instrumentális kezelési módozatok, valamint a nagy mintaszámú, randomizált, kontrollcsoportos arrhythmiavizsgálatok eredményein nyugvó és a szakmai tudományos irányelvek főbb útmutatásait visszatükröző ismeretek friss, kézikönyvbe foglalt szintézise: a tudományág fejlődésével lépést tartó jelen, második, új fejezetek beépítésével és a régebbiek újraírásával, felülvizsgálatával gazdagított kiadás megírása, összeállítása.

Hivatkozás: https://mersz.hu/fazekas-merkely-papp-tenczer-klinikai-sziv-elektrofiziologia-es-aritmologia//

BibTeXEndNoteMendeleyZotero
Kivonat
fullscreenclose
printsave